Eli Lilly and Company
Market Cap
$934.53B
P/E Ratio
43.10
EPS
$22.95
Dividend Yield
0.63%
52-Week Range
$623.78 — $1133.95
Volume
922.58K
Avg Volume
3.06M
Beta
0.43
P/E (TTM)
43.10
Forward P/E
29.10
PEG Ratio
3.53
P/S (TTM)
14.33
P/B (TTM)
33.51
P/FCF
0.00
EV/EBITDA
0.00x
EV/Sales
—
ROE (TTM)
0.98%
ROA (TTM)
0.18%
ROIC
0.00%
Gross Margin
0.84%
Operating Margin
0.46%
Net Margin
0.34%
Debt/Equity
1.60
Current Ratio
1.58
EPS Growth (YoY)
+0.50%
Revenue Growth (YoY)
+0.42%
EPS Growth (3Y)
+0.62%
EPS Growth (5Y)
+0.38%
Sales Growth (3Y)
+0.32%
Sales Growth (5Y)
+0.22%
EPS Est (This Year)
$34.00
EPS Est (Next Year)
$41.48
Dividend Yield
—
Annual Dividend
$1.50
Payout Ratio
0.20%
Frequency
—
Ex-Dividend Date
2025-11-14
Cash/Share
$8.09
Strong Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $1212.18(22.6% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
943.36M
Float
849.32M
Free Float %
90.03%
RSI (14)
48.06
SMA 20
$1049.18
SMA 50
$1051.58
SMA 200
$875.66
ATR (14)
44.19
Volatility (Week)
0.06%
Volatility (Month)
0.03%
Pattern
—
1 Day
-1.92%
1 Week
+2.10%
1 Month
-3.67%
3 Months
+10.84%
6 Months
+61.30%
1 Year
—
YTD
-5.16%
All-Time High
$1133.95
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
1972-06-01
Employees
47000
CEO
David A. Ricks
Index Membership
S&P 500
Website
https://www.lilly.com
Eli Lilly and Company (LLY) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $934.53B, a P/E ratio of 43.10, and a dividend yield of 0.63%, LLY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare LLY against other stocks using dozens of fundamental and technical filters.
Eli Lilly and Company (LLY) has a trailing twelve-month (TTM) P/E ratio of 43.10. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Eli Lilly and Company (LLY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Eli Lilly and Company (LLY) has a market capitalization of $934.53 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Strong Buy" rating on Eli Lilly and Company (LLY) with an average score of 1.50 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $1212.18 implies 22.6% upside from the current price.
Eli Lilly and Company (LLY) has returned -5.16% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.